Vanguard Group
THRN

Vanguard Group’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Vanguard Group’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-860,553
Closed -$8.77M – 4583
2023
Q3 		$8.77M Buy
860,553
+12,678
+1% +$96.5K ﹤0.01% 2954
2023
Q2 		$3.99M Sell
847,875
-9,890
-1% -$45.5K ﹤0.01% 3413
2023
Q1 		$3.96M Sell
857,765
-9,708
-1% -$42.7K ﹤0.01% 3412
2022
Q4 		$3.15M Buy
867,473
+226,454
+35% +$1M ﹤0.01% 3501
2022
Q3 		$3.03M Buy
641,019
+310,419
+94% +$1.56M ﹤0.01% 3581
2022
Q2 		$1.6M Buy
330,600
+36,535
+12% +$222K ﹤0.01% 3901
2022
Q1 		$1.87M Sell
294,065
-12,481
-4% -$67.2K ﹤0.01% 3988
2021
Q4 		$1.9M Buy
306,546
+206,546
+207% +$1.61M ﹤0.01% 4059
2021
Q3 		$865K Buy
+100,000
New +$816K ﹤0.01% 4280

Vanguard Group's THRN Position: Q4 2023 in Review

Vanguard Group sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 860,553 shares — an estimated $8.77M sold.

Vanguard Group first reported a position in THRN in Q3 2021 and held it in 9 quarters. The position peaked at $8.77M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Vanguard Group reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Vanguard Group sold 860,553 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $8.77M.
  • Vanguard Group first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Vanguard Group's Thorne Healthtech, Inc. Common Stock position peaked at $8.77M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.